PBIO

Pressure BioSciences, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 3/07/2017
Contact Info
  • 14 Norfolk Avenue
  • South Easton, MA 02375

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-K
Regulatory Agency Financial Industry Regulatory Authority
CIK 0000830656
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3826 - Analytical instruments
Incorporated In: MA, USA
Year of Inc. 2004
Employees 10 a/o Dec 31, 2016
Company Officers/Contacts
Richard T. Schumacher CEO, President
Joseph L Damasio, Jr. Acting CFO, VP, Fin.
Edmund Ting Senior VP, Engineering
Alexander Lazarev VP, R&D
Nathan P. Lawrence VP, Sales & Mktg.
Company Directors
Jeffrey N. Peterson Chairman, Independent Director, Audit Committee Member, Compensation Committee Member
Vito J. Mangiardi Independent Director, Audit Committee Member, Compensation Committee Member
Kevin A. Pollack Independent Director, Audit Committee Member, Compensation Committee Member
Michael S. Urdea Independent Director
Service Providers
Accounting/Auditing Firm
MaloneBailey, LLP
9801 Westheimer Road
Suite 1100
Houston, TX, 77042
United States
 
Securities Counsel
Lucosky Brookman LLP OTCQX Sponsor
101 Wood Avenue South
5th Floor
Woodbridge, NJ, 08830
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Boston Biomedica, Inc. until 9-04
PBIO Security Details
Share Structure
Market Value1 $9,173,971 a/o Apr 24, 2017
Authorized Shares 100,000,000 a/o Mar 06, 2017
Outstanding Shares 31,639,839 a/o Mar 17, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.01
Shareholders
Shareholders of Record 213 a/o Mar 22, 2017
Short Selling Data
Short Interest 8,342 (614.82%)
Mar 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security